Skip to main content
Log in

Cisplatin/nivolumab

Hypothyroidism and pituitary-adrenocortical hypofunction due to isolated ACTH deficiency: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hihara K, et al. Pituitary-adrenal dysfunction caused by nivolumab for head and neck cancer. Auris Nasus Larynx 46: 896-901, No. 6, Dec 2019. Available from: URL: https://doi.org/10.1016/j.anl.2019.02.005 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cisplatin/nivolumab. Reactions Weekly 1771, 99 (2019). https://doi.org/10.1007/s40278-019-67918-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-67918-2

Navigation